OverviewChartNewsTraderScreen

DZ Bank Aktienanleihe MRK 26.06.2.../  DE000DJ53RK2  /

Frankfurt Zert./DZB
5/30/2024  3:34:55 PM Chg.-0.050 Bid5/30/2024 Ask5/30/2024 Underlying Strike price Expiration date Option type
100.370EUR -0.05% 100.370
Bid Size: 100,000		 100.470
Ask Size: 100,000		 MERCK KGAA O.N. 142.857 - 6/26/2024 Call
GlobeNewswire 1:00 PM Monte Rosa Therapeutics Announces Leadership Team Promotions
GlobeNewswire 1:00 PM LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference
TeleTrader 5/29 Merck to buy biotech firm EyeBio for up to $3B
GlobeNewswire 5/29 Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire 5/29 Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study
GlobeNewswire 5/7 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 5/6 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire 5/2 Cerevance Achieves First Milestone in Research Collaboration with Merck
TeleTrader 4/25 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 4/2 Vaccinex Reports 2023 Financial Results and Provides Corporate Update
GlobeNewswire 3/4 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
TeleTrader 2/2 Merck Group to expand investment in South Korea
TeleTrader 2/1 Merck's Q4 sales up 6% to $14.6B
TeleTrader 1/27 J&J, Merck CEOs to testify before Senate on drug prices
GlobeNewswire 1/23 Unnatural Products, Inc. Enters Research Collaboration with Merck
GlobeNewswire 12/21/2023 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire 12/14/2023 ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
TeleTrader 10/26/2023 Merck's Q3 sales up 7% to $16B
TeleTrader 10/20/2023 Daiichi Sankyo, Merck announce collaboration on cancer drugs
GlobeNewswire 10/17/2023 ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA
GlobeNewswire 9/28/2023 Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration
TeleTrader 8/29/2023 US gov't reveals drugs subject to Medicare price debate
TeleTrader 8/1/2023 Merck posts Q2 sales of $15B, rising 3%
TeleTrader 6/6/2023 WH defends Medicare over Merck lawsuit
TeleTrader 6/6/2023 Merck sues US gov't over drug price negotiations